GlassScriptPhysician profile
Spandan Patel
NPI 1902247604
$2,193.32
in general payments reported to CMS, 2019-2025
9 companies · $1,056 in 2025
The $1,056 reported for 2025 was more than what 78% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $116 · 2022: $249 · 2023: $423 · 2024: $350 · 2025: $1,056.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,828.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,827.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $987.32 | 2023-2025 | Impella |
| La Jolla Pharmaceutical Company | $298.83 | 2023-2025 | Giapreza |
| Abbvie INC. | $240.37 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $144.74 | 2024 | Uptravi, Opsumit |
| Ferring Pharmaceuticals INC. | $125.89 | 2023 | Rebyota |
| Shionogi INC | $125.00 | 2022 | |
| Stryker Corporation | $97.64 | 2025 | Clottriever Bold Catheter |
| Inari Medical, INC. | $97.28 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Olympus America INC. | $76.25 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Spandan Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.